...
search icon
cvkd-img

Cadrenal Therapeutics, Inc. Common Stock, Common Stock

CVKD

NAQ

$16.27

-$0.28

(-1.69%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$29.00M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
33.95K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.4 L
$32.55 H
$16.27

About Cadrenal Therapeutics, Inc. Common Stock, Common Stock

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCVKDSectorS&P500
1-Week Return2.65%0.49%-0.42%
1-Month Return28.72%-3.1%-2.2%
3-Month Return44.36%-8.59%2.38%
6-Month Return133.26%-4.57%5.1%
1-Year Return64.34%-0.94%23.79%
3-Year Return-73.67%2.88%26.66%

Financials

Dec '22Dec '23
Total Revenue--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue1.27K1.98K[{"date":"2022-12-31","value":63.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(1.27K)(1.98K)[{"date":"2022-12-31","value":-126600,"profit":false},{"date":"2023-12-31","value":-198000,"profit":false}]
Gross Margin-(Infinity%)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses2.70M7.63M[{"date":"2022-12-31","value":35.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(2.70M)(7.63M)[{"date":"2022-12-31","value":-270163000,"profit":false},{"date":"2023-12-31","value":-763284300,"profit":false}]
Total Non-Operating Income/Expense-(492.25K)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-49225200,"profit":false}]
Pre-Tax Income(6.71M)(8.36M)[{"date":"2022-12-31","value":-671432900,"profit":false},{"date":"2023-12-31","value":-835708600,"profit":false}]
Income Taxes4.00(165.91K)[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4147875,"profit":false}]
Income After Taxes-(8.19M)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-819117100,"profit":false}]
Income From Continuous Operations-(8.36M)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-835708600,"profit":false}]
Income From Discontinued Operations--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(6.71M)(8.36M)[{"date":"2022-12-31","value":-671432900,"profit":false},{"date":"2023-12-31","value":-835708600,"profit":false}]
EPS (Diluted)(0.91)(8.03)[{"date":"2022-12-31","value":-91,"profit":false},{"date":"2023-12-31","value":-803.29,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CVKD
Cash Ratio 3.44
Current Ratio 3.69

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CVKD
ROA (LTM) -70.99%
ROE (LTM) -125.15%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CVKD
Debt Ratio Lower is generally better. Negative is bad. 0.27
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.73

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CVKD
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 8.65
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.21

FAQs

What is Cadrenal Therapeutics, Inc. Common Stock share price today?

Cadrenal Therapeutics, Inc. Common Stock (CVKD) share price today is $16.27

Can Indians buy Cadrenal Therapeutics, Inc. Common Stock shares?

Yes, Indians can buy shares of Cadrenal Therapeutics, Inc. Common Stock (CVKD) on Vested. To buy Cadrenal Therapeutics, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CVKD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cadrenal Therapeutics, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Cadrenal Therapeutics, Inc. Common Stock (CVKD) via the Vested app. You can start investing in Cadrenal Therapeutics, Inc. Common Stock (CVKD) with a minimum investment of $1.

How to invest in Cadrenal Therapeutics, Inc. Common Stock shares from India?

You can invest in shares of Cadrenal Therapeutics, Inc. Common Stock (CVKD) via Vested in three simple steps:

  • Click on Sign Up or Invest in CVKD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cadrenal Therapeutics, Inc. Common Stock shares
What is Cadrenal Therapeutics, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is $32.55. The 52-week low price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is $5.4.

What is Cadrenal Therapeutics, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is

What is Cadrenal Therapeutics, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 8.65

What is Cadrenal Therapeutics, Inc. Common Stock dividend yield?

The dividend yield of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 0.00%

What is the Market Cap of Cadrenal Therapeutics, Inc. Common Stock?

The market capitalization of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is $29.00M

What is Cadrenal Therapeutics, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Cadrenal Therapeutics, Inc. Common Stock is CVKD

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top